Youcare Pharmaceutical Group (688658) Stock Overview
Engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
688658 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Youcare Pharmaceutical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥20.63 |
| 52 Week High | CN¥36.49 |
| 52 Week Low | CN¥11.90 |
| Beta | 0.64 |
| 1 Month Change | -6.86% |
| 3 Month Change | -33.54% |
| 1 Year Change | -8.27% |
| 3 Year Change | -2.83% |
| 5 Year Change | n/a |
| Change since IPO | -34.80% |
Recent News & Updates
Recent updates
These 4 Measures Indicate That Youcare Pharmaceutical Group (SHSE:688658) Is Using Debt Reasonably Well
Mar 03
Positive Sentiment Still Eludes Youcare Pharmaceutical Group Co., Ltd. (SHSE:688658) Following 27% Share Price Slump
Dec 27Improved Revenues Required Before Youcare Pharmaceutical Group Co., Ltd. (SHSE:688658) Stock's 34% Jump Looks Justified
Oct 14Youcare Pharmaceutical Group (SHSE:688658) Takes On Some Risk With Its Use Of Debt
Sep 25Investors Can Find Comfort In Youcare Pharmaceutical Group's (SHSE:688658) Earnings Quality
Aug 29Youcare Pharmaceutical Group Co., Ltd.'s (SHSE:688658) Price Is Out Of Tune With Earnings
Aug 16Youcare Pharmaceutical Group Co., Ltd. (SHSE:688658) Shares May Have Slumped 26% But Getting In Cheap Is Still Unlikely
Apr 21There's Reason For Concern Over Youcare Pharmaceutical Group Co., Ltd.'s (SHSE:688658) Massive 26% Price Jump
Mar 04Shareholder Returns
| 688658 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -4.8% | -2.6% | 0.5% |
| 1Y | -8.3% | 11.7% | 17.3% |
Return vs Industry: 688658 underperformed the CN Pharmaceuticals industry which returned 11.9% over the past year.
Return vs Market: 688658 underperformed the CN Market which returned 17.2% over the past year.
Price Volatility
| 688658 volatility | |
|---|---|
| 688658 Average Weekly Movement | 7.9% |
| Pharmaceuticals Industry Average Movement | 4.5% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in CN Market | 9.4% |
| 10% least volatile stocks in CN Market | 3.0% |
Stable Share Price: 688658's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 688658's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 3,033 | Fei Yu | www.youcareyk.com |
Youcare Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It offers drugs in various forms, such as injection, lyophilized powder for injection, concentrated pills, tablets, capsules, gelatins, ointments, creams, granules, etc. The company provides drugs in various categories, including antibiotics, gastrointestinal, external, dermatology, vitamin, hypoglycemic, respiratory system, antibacterial, antineoplastic, antiviral, lipid-regulating agent, anti-hepatitis, anti- tumor, cardio-cerebral, and immunomodulation. Youcare Pharmaceutical Group Co., Ltd.
Youcare Pharmaceutical Group Co., Ltd. Fundamentals Summary
| 688658 fundamental statistics | |
|---|---|
| Market cap | CN¥9.17b |
| Earnings (TTM) | -CN¥233.99m |
| Revenue (TTM) | CN¥2.55b |
Is 688658 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688658 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.55b |
| Cost of Revenue | CN¥1.34b |
| Gross Profit | CN¥1.20b |
| Other Expenses | CN¥1.44b |
| Earnings | -CN¥233.99m |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
Nov 20, 2025
| Earnings per share (EPS) | -0.53 |
| Gross Margin | 47.24% |
| Net Profit Margin | -9.18% |
| Debt/Equity Ratio | 19.4% |
How did 688658 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/07 16:45 |
| End of Day Share Price | 2025/11/07 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Youcare Pharmaceutical Group Co., Ltd. is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shitong Han | Citic Securities Co., Ltd. |
| Fan Yang | Citic Securities Co., Ltd. |
| Zhengyang Wang | Citic Securities Co., Ltd. |